Strategic Provider of End-to-End Automation Solutions

Driving Performance and Innovation ATS Strategic Approach to M&A will Remain a Key Growth Driver. Targeting Value Creation in Attractive Markets What We Look For • Growth oriented Attractive Markets • • Strategic Value • • • • Low cyclicality Regulated spaces Differentiated technology Innovative products Niche applications Geographic penetration • Operational Ability to manage • Fit . • Financial • Returns • • Synergy potential ABM implementation ROIC Cost of capital Strong EBITDA potential Reoccurring revenue EPS accretion Recent Acquisitions SP Acquired: Dec 2021 Price: US$450mm End Market Exposure • Life Sciences CFT LEADERS INNOVATE Acquired: Mar 2021 Price: C$260mm End Market Exposure Food COMECER Acquired: Feb 2019 Price: €113mm End Market Exposure • Life Sciences Other Acquisitions Avidity Biomedical Equipment Provider Expected Close: Fourth Calendar Quarter of 2023 Odyssey Digitalization Solutions Provider Acquired: July 2023 Yazzoom Al Process Optimizer Acquired: June 2023 Triad Reliability Engineering Provider Acquired: March 2023 Zi-Argus Automation System Integrator Acquired: March 2023 IPCOS Production Process Optimization Acquired: Dec 2022 HSG Pharma System Integrator Acquired: Dec 2021 BioDot Fluid Dispensing Equipment Provider Acquired June 2021 Successfully Executing Our Playbook . • • Over $1.4 billion of capital deployed towards M&A since 2017 19 acquired companies add differentiated capabilities and end market exposure Proven integration playbook applied consistently across all acquisitions Same rigorous criteria applied to existing portfolio regularly 12 TM

View entire presentation